文献速递心律失常

磷酸二酯酶8调控持续性房颤L型钙电流降低的新机制

Phosphodiesterase 8 governs cAMP/PKA-dependent reduction of L-type calcium current in human atrial fibrillation: a novel arrhythmogenic mechanism.
PubMed 文献 · Eur Heart J · 2023-01-01

本研究探讨磷酸二酯酶8(PDE8)亚型在持续性房颤(cAF)患者中降低L型钙电流(ICa,L)的作用。通过检测PDE8A/B表达与定位及功能实验,发现PDE8B2与Cav1.2α1C亚基结合增强导致ICa,L降低,选择性抑制PDE8可挽救该电流,提示PDE8B2上调是cAF促心律失常新机制。

要点

  • PDE8A在阵发性房颤中升高,PDE8B仅在持续性房颤中上调。
  • PDE8B2与Cav1.2α1C结合增强导致Ser1928磷酸化降低和ICa,L减少。
  • 选择性抑制PDE8可恢复ICa,L并延长动作电位复极50%时程。

核心结论

  • PDE8B2上调通过直接结合Cav1.2α1C亚基降低ICa,L,可能是持续性房颤促心律失常的新分子机制。

研究设计与样本

  • 研究对比窦性心律、阵发性房颤和持续性房颤患者心房组织与心肌细胞,采用RT-qPCR、western blot、免疫共沉淀、免疫荧光、FRET、膜片钳和锐电极记录检测PDE8A/B表达、定位与功能。

主要发现

  • PDE8A基因和蛋白水平在阵发性房颤较窦性心律患者升高,而PDE8B仅在持续性房颤中上调。
  • 持续性房颤心肌细胞中PDE8B2与Cav1.2α1C结合显著增加,Cav1.2α1C Ser1928磷酸化降低并伴随ICa,L下降。
  • 选择性抑制PDE8可增加Cav1.2α1C Ser1928磷酸化、提升亚膜cAMP并挽救持续性房颤降低的ICa,L,同时延长动作电位复极50%时程。

临床怎么用

  • PDE8B2可能作为持续性房颤中ICa,L降低的分子标志物,选择性PDE8抑制或为改善房颤钙电流重构的潜在策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Atrial fibrillation (AF) is associated with altered cAMP/PKA signaling and an AF-promoting reduction of L-type Ca2+-current (ICa,L), the mechanisms of which are poorly understood. Cyclic-nucleotide phosphodiesterases (PDEs) degrade cAMP and regulate PKA-dependent phosphorylation of key calcium-handling proteins, including the ICa,L-carrying Cav1.2α1C subunit. The aim was to assess whether altered function of PDE type-8 (PDE8) isoforms contributes to the reduction of ICa,L in persistent (chronic) AF (cAF) patients. METHODS AND RESULTS: mRNA, protein levels, and localization of PDE8A and PDE8B isoforms were measured by RT-qPCR, western blot, co-immunoprecipitation and immunofluorescence. PDE8 function was assessed by FRET, patch-clamp and sharp-electrode recordings. PDE8A gene and protein levels were higher in paroxysmal AF (pAF) vs. sinus rhythm (SR) patients, whereas PDE8B was upregulated in cAF only. Cytosolic abundance of PDE8A was higher in atrial pAF myocytes, whereas PDE8B tended to be more abundant at the plasmalemma in cAF myocytes. In co-immunoprecipitation, only PDE8B2 showed binding to Cav1.2α1C subunit which was strongly increased in cAF. Accordingly, Cav1.2α1C showed a lower phosphorylation at Ser1928 in association with decreased ICa,L in cAF. Selective PDE8 inhibition increased Ser1928 phosphorylation of Cav1.2α1C, enhanced cAMP at the subsarcolemma and rescued the lower ICa,L in cAF, which was accompanied by a prolongation of action potential duration at 50% of repolarization. CONCLUSION: Both PDE8A and PDE8B are expressed in human heart. Upregulation of PDE8B isoforms in cAF reduces ICa,L via direct interaction of PDE8B2 with the Cav1.2α1C subunit. Thus, upregulated PDE8B2 might serve as a novel molecular mechanism of the proarrhythmic reduction of ICa,L in cAF.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Grammatika Pavlidou N, Dobrev S, Beneke K, et al. Phosphodiesterase 8 governs cAMP/PKA-dependent reduction of L-type calcium current in human atrial fibrillation: a novel arrhythmogenic mechanism. Eur Heart J. 2023. PMID: 36810794. doi:10.1093/eurheartj/ehad086

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。